Menu

BeyondSPX has rebranded as EveryTicker. We now operate at everyticker.com, reflecting our coverage across nearly all U.S. tickers. BeyondSPX has rebranded as EveryTicker.

Price Performance Heatmap

5Y Price (Market Cap Weighted)

All Stocks (1093)

Company Market Cap Price
GRFS Grifols, S.A.
The ISARD diagnostics platform and related testing capabilities position Grifols in Diagnostic Equipment.
$7.51B
$8.82
+1.85%
ESE ESCO Technologies Inc.
Diagnostic Equipment reflects ESCO's diagnostic testing instruments and related software for measurement and monitoring.
$7.25B
$275.63
-1.76%
GKOS Glaukos Corporation
Glaukos directly manufactures ophthalmology devices, including iStent MIGS implants used in eye surgeries.
$6.63B
$115.36
-0.01%
BLCO Bausch + Lomb Corporation
Ophthalmology Devices – direct manufacture and sale of eye-care surgical devices and related ophthalmic equipment.
$6.39B
$18.04
-0.06%
AVTR Avantor, Inc.
Avantor provides Laboratory Testing & Advisory Services, aligning with outsourced testing and regulatory support offerings.
$5.90B
$8.71
+0.75%
VNT Vontier Corporation
Repair Solutions includes diagnostic equipment launches for vehicle repair workflows.
$5.88B
$40.06
-1.16%
BRKR Bruker Corporation
Bruker directly manufactures diagnostic instrumentation and analytical equipment such as MALDI Biotyper and other diagnostic/imaging instruments.
$5.54B
$37.61
+3.01%
MIR Mirion Technologies, Inc.
Core business: Mirion designs and manufactures medical devices and biometric sensing equipment used in radiology, radiation therapy, and nuclear medicine.
$5.48B
$21.48
-0.58%
IPGP IPG Photonics Corporation
IPG markets medical laser systems including thulium lasers for urology, fitting Medical Devices & Biometrics.
$5.45B
$127.36
-1.48%
PLXS Plexus Corp.
Healthcare/Life Sciences end-market, with Plexus serving medical devices and related equipment through its engineering and manufacturing services.
$5.30B
$198.00
+0.02%
STVN Stevanato Group S.p.A.
Directly manufactures Prefillable Syringes used for sterile biologic and small-molecule injections.
$5.30B
$17.48
-0.11%
TFX Teleflex Incorporated
Teleflex is a global medical device company designing, manufacturing, and selling single-use medical devices across critical care, surgical, and interventional markets.
$5.27B
$117.17
-1.69%
LNTH Lantheus Holdings, Inc.
Liquid imaging agents (PET tracers and ultrasound contrast) place the company squarely in medical imaging as a core business.
$5.16B
$76.70
-1.46%
TMDX TransMedics Group, Inc.
TransMedics' Organ Care System (OCS) is a proprietary medical device platform for organ preservation and monitoring.
$5.05B
$146.34
-0.89%
NOVT Novanta Inc.
Medical Devices & Biometrics aligning with their focus on medical devices and biometric sensing technologies.
$5.03B
$139.72
-0.65%
GNTX Gentex Corporation
Medical Devices & Biometrics covers EyeLock iris biometrics and eSight medical device initiatives tied to Gentex's diversification.
$5.01B
$22.86
-0.04%
OSIS OSI Systems, Inc.
Patient Monitoring represents next-generation monitoring platforms and solutions within healthcare offerings.
$4.90B
$287.50
-0.38%
ALKS Alkermes plc
Prefillable syringes as a packaging/administration technology for injectable products.
$4.83B
$28.78
-1.71%
NVST Envista Holdings Corp
Envista directly manufactures dental equipment, including implants and aligners, a core product line.
$4.67B
$28.38
-0.18%
SHC Sotera Health Company
Nelson Labs provides outsourced microbiological and analytical chemistry testing plus regulatory advisory services.
$4.48B
$15.35
-2.60%
MMSI Merit Medical Systems, Inc.
Vascular/interventional devices focus, including WRAPSODY endoprosthesis for dialysis access.
$4.40B
$73.81
-0.47%
AMRX Amneal Pharmaceuticals, Inc.
DHE autoinjector (Brekiya) approval signals involvement in auto-injector device delivery systems.
$4.18B
$13.04
-1.92%
IRTC iRhythm Technologies, Inc.
Direct product: iRhythm's patch-based patient monitoring device and associated software for continuous cardiac monitoring.
$4.12B
$127.91
-0.03%
HIMS Hims & Hers Health, Inc.
Laboratory testing & advisory services core to in-house lab capabilities.
$3.74B
$16.63
+1.09%
LIVN LivaNova PLC
Directly manufactures/distributes Neuromodulation Devices, including VNS Therapy and proximal hypoglossal nerve stimulation systems.
$3.56B
$64.28
-1.50%
ICUI ICU Medical, Inc.
Medical Device Consumables includes disposable items used with infusion therapy (Clave connectors, ChemoLock/ChemoClave CSTDs) and is a core revenue stream.
$3.52B
$140.28
-1.53%
SXI Standex International Corporation
Specialty diagnostic/temperature-controlled healthcare equipment in the Scientific segment.
$3.21B
$265.00
+0.02%
ATS ATS Corporation
ATS-related offerings intersect with Medical Devices & Biometrics via automated production of regulated devices.
$3.13B
$32.27
+0.03%
HAE Haemonetics Corporation
Haemonetics manufactures medical devices and biometrics for hospital blood management and plasma processing.
$3.03B
$64.36
-0.47%
CON Concentra Group Holdings Parent, Inc.
Laboratory testing & advisory services are part of the occupational health testing offerings and regulatory/compliance support seen in the business model.
$3.02B
$23.37
-0.81%
ITGR Integer Holdings Corporation
The company manufactures medical devices and biometrics (sensors), aligning with the investable theme Medical Devices & Biometrics.
$3.01B
$86.03
LQDA Liquidia Corporation
YUTREPIA includes a dry-powder inhaler device component, aligning with medical devices and equipment category.
$2.96B
$35.00
+1.80%
VCYT Veracyte, Inc.
The company offers MRD and other liquid biopsy tests, placing it in the liquid biopsy space.
$2.87B
$35.85
-1.16%
TXG 10x Genomics, Inc.
TXG directly manufactures and sells diagnostic instrument platforms for single-cell and spatial biology workflows.
$2.83B
$21.87
-2.24%
UCTT Ultra Clean Holdings, Inc.
Provides laboratory testing and advisory services relevant to semiconductor manufacturing cleanliness and optimization.
$2.68B
$57.81
-1.97%
BBU Brookfield Business Partners L.P.
Healthscope operates hospital services, a healthcare services/ facilities business.
$2.56B
$34.38
-0.35%
BBUC Brookfield Business Corporation
Operates private hospitals and related hospital services.
$2.54B
$34.77
-0.16%
ADPT Adaptive Biotechnologies Corporation
ADPT directly provides clonoSEQ MRD diagnostic testing and related laboratory services.
$2.51B
$16.09
-2.13%
LMAT LeMaitre Vascular, Inc.
Directly produces vascular interventional devices (grafts, patches, shunts, catheters) used in vascular surgery.
$2.41B
$106.57
+0.15%
← Previous
1 2 3 4 5 ... 11
Next →
Showing page 3 of 11 (1093 total stocks)

Loading company comparison...

Loading research report...

HIMS Hims & Hers Health, Inc.

Hims & Hers Resumes Sales of Compounded GLP‑1 Weight‑Loss Pill After FDA and DOJ Scrutiny

Mar 04, 2026
STVN Stevanato Group S.p.A.

Stevanato Group Reports Q4 2025 Earnings Beat, Highlights Growth in High‑Value Solutions

Mar 04, 2026
TFX Teleflex Incorporated

Teleflex Reports 2025 Financial Results and 2026 Outlook

Feb 27, 2026
LMAT LeMaitre Vascular, Inc.

LeMaitre Vascular Reports 16% Q4 2025 Revenue Growth, Beats EPS Estimate, Raises 2026 Guidance

Feb 26, 2026
TFX Teleflex Incorporated

Teleflex Reports Q4 2025 Earnings: Revenue Misses Estimates, Guidance Cut for 2026

Feb 26, 2026
VCYT Veracyte, Inc.

Veracyte Beats Q4 2025 Earnings, Confirms Strong 2026 Guidance

Feb 26, 2026
LIVN LivaNova PLC

LivaNova Reports Q4 2025 Earnings Beat; 2026 Guidance Signals Moderate Growth Amid OSA Investment

Feb 25, 2026
MMSI Merit Medical Systems, Inc.

Merit Medical Systems Beats Q4 2025 Earnings, Confirms Strong FY2026 Outlook

Feb 25, 2026
TMDX TransMedics Group, Inc.

TransMedics Reports Strong Q4 2025 Earnings, Beats Estimates, Raises 2026 Revenue Outlook

Feb 25, 2026
HAE Haemonetics Corporation

Haemonetics Receives FDA Clearance for NexSys PCS Plasma Collection System with Persona PLUS

Feb 24, 2026
SHC Sotera Health Company

Sotera Health Beats Q4 2025 Earnings, Highlights Strong Revenue Growth and Guidance

Feb 24, 2026
LIVN LivaNova PLC

LivaNova and Orrum Clinical Analytics Announce Integration of Essenz Perfusion System with CŌRE Insights Platform

Feb 21, 2026
ICUI ICU Medical, Inc.

ICU Medical Reports Q4 2025 Results: Revenue Declines, EPS Beats, and FY 2026 Guidance Highlights Margin Expansion

Feb 20, 2026
IRTC iRhythm Technologies, Inc.

iRhythm Reports Strong Q4 2025 Earnings, First Positive GAAP Net Income

Feb 20, 2026
HIMS Hims & Hers Health, Inc.

Hims & Hers Health to Acquire Eucalyptus for $1.15 Billion, Expanding Global Footprint

Feb 19, 2026
ITGR Integer Holdings Corporation

Integer Holdings Reports Q4 2025 Earnings, Beats Estimates, Maintains 2026 Outlook

Feb 19, 2026
BLCO Bausch + Lomb Corporation

Bausch + Lomb Reports Q4 2025 Earnings, Misses EPS but Beats Revenue, Maintains 2026 Guidance

Feb 18, 2026
GKOS Glaukos Corporation

Glaukos Reports Record Q4 2025 Earnings, Beats Revenue Estimates, Misses EPS

Feb 18, 2026
TXG 10x Genomics, Inc.

10x Genomics Reports Q4 2025 Earnings: Revenue Beats Estimates, Guidance Holds Steady

Feb 13, 2026
BRKR Bruker Corporation

Bruker Reports Q4 2025 Earnings: Revenue Slightly Down, EPS Misses Estimates, Guidance Holds

Feb 12, 2026
MIR Mirion Technologies, Inc.

Mirion Technologies Reports Q4 and Full‑Year 2025 Results: Revenue $925.4 M, Adjusted EBITDA $227.9 M, EPS Misses

Feb 11, 2026
BRKR Bruker Corporation

Bruker Unveils iNTApharma, a Native‑State Nanoparticle Characterization Platform

Feb 10, 2026
HIMS Hims & Hers Health, Inc.

Novo Nordisk Sues Hims & Hers Over Compounded Semaglutide Pill, Threatening Weight‑Loss Segment

Feb 10, 2026
TMDX TransMedics Group, Inc.

TransMedics Secures Full FDA IDE Approval for Next‑Generation OCS Heart Trial, Paving Way for Expanded Organ‑Care Portfolio

Feb 09, 2026
HIMS Hims & Hers Health, Inc.

FDA and HHS Target Hims & Hers’ Compounded GLP‑1 Weight‑Loss Drugs

Feb 07, 2026
HAE Haemonetics Corporation

Haemonetics Reports Q3 Fiscal 2026 Earnings: Revenue Declines 2.7% YoY, Adjusted EPS Beats Estimates, Guidance Raised

Feb 06, 2026
NVST Envista Holdings Corp

Envista Holdings Beats Q4 2025 Earnings Estimates, Highlights Strong Growth in Core Segments

Feb 06, 2026
HAE Haemonetics Corporation

Haemonetics Reports Q3 2025 Earnings Beat, Raises Full‑Year Guidance

Feb 05, 2026
HIMS Hims & Hers Health, Inc.

Hims & Hers Launches Compounded Semaglutide Pill at $49

Feb 05, 2026
TXG 10x Genomics, Inc.

10x Genomics Partners with UK Consortium PharosAI to Build AI‑Ready Cancer Dataset

Feb 04, 2026